Diagnostic Ventures is proud to work with leading PhD researchers at Brigham Young University. Our rapid sepsis diagnostic technology has been in development since 2016 and can currently detect the 5 most deadly sepsis pathogens in as little as 90 minutes.
Originally funded by a $5.2M grant from the National Institute of Health, testing is being expanded to cover 90%+ of sepsis-causing pathogens and resistance genes.
This product is under development and not approved for sale. This product is not yet FDA approved.
Blood with bacteria
Spin Blood
Separate Pathogens from Interferents via Sedimentary Forces
Slow to separate plasma from Interferents